Certolizumab Pegol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB08904 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 45 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | rheumatoid vasculitis | KG + DL |
| 2 | hypermobility of coccyx | KG + DL |
| 3 | inflammatory spondylopathy | KG + DL |
| 4 | Kummell disease | KG + DL |
| 5 | polyarticular juvenile rheumatoid arthritis | KG + DL |
| 6 | vertebral disease | KG + DL |
| 7 | mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency | KG + DL |
| 8 | brachydactyly-syndactyly syndrome | KG + DL |
| 9 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 10 | tenosynovitis | KG + DL |
| 11 | polyp of vocal cord | KG + DL |
| 12 | polyp of middle ear | KG + DL |
| 13 | epulis | KG + DL |
| 14 | polyp of frontal sinus | KG + DL |
| 15 | polyp of ureter | KG + DL |
| 16 | polyp of external auditory canal | KG + DL |
| 17 | uterine polyp | KG + DL |
| 18 | polyp of vulva | KG + DL |
| 19 | fibroepithelial polyp | KG + DL |
| 20 | neoplastic polyp | KG + DL |
| 21 | anus disease | KG + DL |
| 22 | seborrheic dermatitis | KG + DL |
| 23 | ulcerative colitis (disease) | KG + DL |
| 24 | functional neutrophil defect | KG + DL |
| 25 | WHIM syndrome | KG + DL |
| 26 | granulomatous disease with defect in neutrophil chemotaxis | KG + DL |
| 27 | granulomatous disease, chronic, autosomal recessive, 5 | KG + DL |
| 28 | Crohn disease of the esophagus | KG + DL |
| 29 | spondyloepimetaphyseal dysplasia, Handigodu type | KG + DL |
| 30 | Czech dysplasia, metatarsal type | KG + DL |
| 31 | platyspondylic dysplasia, Torrance type | KG + DL |
| 32 | heparin cofactor 2 deficiency | KG + DL |
| 33 | avascular necrosis of femoral head, primary | KG + DL |
| 34 | fibroma | KG + DL |
| 35 | spondylometaphyseal dysplasia, Schmidt type | KG + DL |
| 36 | congenital hypotrichosis with juvenile macular dystrophy | KG + DL |
| 37 | Stickler syndrome, type I, nonsyndromic ocular | KG + DL |
| 38 | megaepiphyseal dwarfism | KG + DL |
| 39 | gout | KG + DL |
| 40 | mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis | KG + DL |
| 41 | gingival hypertrophy | KG + DL |
| 42 | spondyloperipheral dysplasia-short ulna syndrome | KG + DL |
| 43 | antithrombin deficiency type 2 | KG + DL |
| 44 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 45 | anti-glomerular basement membrane disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.